INSULATARD INNOLET 100 IU/ml, suspension for injection in a pre-filled pen 5 pens of 3 ml
Brand page: Insulatard (isophane human insulin) — all forms and strengths in France
Active ingredients: INSULINE HUMAINE RECOMBINANTE ISOPHANE
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for injection5 pens of 3 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- INSULATARD INNOLET 100 unités internationales/ml, suspension injectable en stylo prérempli
- Pharmaceutical form
- suspension injectable
- Route of administration
- sous-cutanée
- Presentation description
- 5 cartouche(s) en verre de 3 ml dans stylo pré-rempli
- Marketing authorisation holder
- NOVO NORDISK (DANEMARK)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Feb 2024
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62457123CIP73611997CIP133400936119970Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| INSULINE HUMAINE RECOMBINANTE ISOPHANEsuspension | 100 UI · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.